SCHEMBL7871129

SCHEMBL7871129

COC(=O)C(CCSC)NC(=O)c1ccc(CNCc2ccco2)cc1-c1ccccc1

nearest known ligand 0.85

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
FNTA P49354 8/20 0.85
FNTB P49356 8/20 0.85
TDP1 Q9NUW8 1/20 0.54
ICMT O60725 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7871133 1.00 FNTA (0.85) FNTAFNTBTDP1ICMT
Lithium SCHEMBL6628599 0.91 FNTA (0.98) FNTAFNTBTDP1
SCHEMBL6628596 0.91 FNTA (0.98) FNTAFNTBTDP1
Lithium Ion SCHEMBL6628591 0.90 FNTA (0.85) FNTAFNTB
SCHEMBL6774843 0.83 FNTA (0.65) FNTAFNTBTDP1
SCHEMBL6774846 0.83 FNTA (0.65) FNTAFNTBTDP1
SCHEMBL6624287 0.81 FNTA (0.62) FNTAFNTBTDP1
SCHEMBL6774699 0.81 FNTA (0.65) FNTAFNTBTDP1
SCHEMBL6775608 0.81 FNTA (0.62) FNTAFNTBTDP1
SCHEMBL6624253 0.81 FNTA (0.65) FNTAFNTBTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310095-B1 INHIBITING OR TREATING CANCER, TREATING INTIMAL HYPERPLASIA ASSOCIATED WITH RESTENOSIS AND ATHEROSCLEROSIS, INHIBITING POST-TRANSLATIONAL MODIFICATION OF ONCOGENIC RAS PROTEIN BY PROTEIN FARNESYLTRANSFERASE AND/OR GERANYLGERANYLTRANSFERASE UNIVERSITY OF PITTSBURGH 2001-10-30 US disclosed